About: Collaborative Management Strategies for Drug Shortages in Neurocritical Care

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Collaborative Management Strategies for Drug Shortages in Neurocritical Care Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Collaborative Management Strategies for Drug Shortages in Neurocritical Care
Creator	Clark, Sarah Patel, Deepa Armahizer, Michael Barra, Megan Chester, Katleen Levasseur-Franklin, Kimberly Pajoumand, Mehrnaz Tully, Andrea
Source	PMC
abstract	Drug shortages have become all too familiar in the health care environment, with over 200 drugs currently on shortage. In the wake of Hurricane Maria in September 2017, hospitals across the USA had to quickly and creatively adjust medication preparation and administration techniques in light of decreased availability of intravenous (IV) bags used for compounding a vast amount of medications. Amino acid preparations, essential for compounding parenteral nutrition, were also directly impacted by the hurricane. Upon realization of the impending drug shortages, hospitals resorted to alternative methods of drug administration, such as IV push routes, formulary substitutions, or alternative drug therapies in hopes of preserving the small supply of IV bags available and prioritizing them for them most critical needs. In some cases, alternative drug therapies were required, which increased the risk of medication errors due to the use of less-familiar treatment options. Clinical pharmacists rounding with medical teams provided essential, patient-specific drug regimen alternatives to help preserve a dwindling supply while ensuring use in the most critical cases. Drug shortages also frequently occur in the setting of manufacturing delays or discontinuation and drug recalls, with potential to negatively impact patient care. The seriousness of the drug shortage crisis reached public attention by December 2017, when political and pharmacy organizations called for response to the national drug shortage crisis. In this article, we review institutional mitigation strategies in response to drug shortages and discuss downstream effects of these shortages, focusing on medications commonly prescribed in neurocritical care patients.
has issue date	2019-05-10(xsd:dateTime)
bibo:doi	10.1007/s12028-019-00730-7
bibo:pmid	31077080
has license	no-cc
sha1sum (hex)	84b3ed1a9a7a40089e70e59055546d4add6faca4
schema:url	https://doi.org/10.1007/s12028-019-00730-7
resource representing a document's title	Collaborative Management Strategies for Drug Shortages in Neurocritical Care
has PubMed Central identifier	PMC7222107
has PubMed identifier	31077080
schema:publication	Neurocrit Care
resource representing a document's body	covid:84b3ed1a9a7a40089e70e59055546d4add6faca4#body_text
is schema:about of	named entity 'supply' named entity 'alternatives' named entity 'organizations' named entity 'compounding' named entity 'options' named entity 'Drug' named entity 'DISCUSS' named entity 'DRUGS' named entity 'EFFECTS' named entity 'TO HELP' named entity 'CURRENTLY' named entity 'CRISIS' named entity 'REALIZATION' named entity 'DUE TO' named entity 'ORGANIZATIONS' named entity 'PATIENT' named entity 'SERIOUSNESS' named entity 'MARIA' named entity 'USE' named entity 'MITIGATION' named entity 'drug therapies' named entity 'pharmacy' named entity 'administration' named entity 'hospitals' named entity 'routes' named entity 'critical' named entity 'hopes' named entity 'care' named entity 'bags' named entity 'essential' named entity 'treatment options' named entity 'compounding' named entity 'compounding' named entity 'Neurocritical Care' named entity 'supply management' named entity 'GPIIb/IIIa' named entity 'Pharmacy and Therapeutics' named entity 'immune suppression' named entity 'adverse events' named entity 'amino acids' named entity 'Levetiracetam' named entity 'alternative therapies' named entity 'liver dysfunction' named entity 'anti-fibrinolytic' named entity 'platelets' named entity 'abciximab' named entity 'routes of administration' named entity '3, 4' named entity 'concomitant disease' named entity 'peripheral nerve' named entity 'e-mail' named entity 'infusion' named entity 'targeted temperature management' named entity 'opioid' named entity 'endovascular' named entity 'continuous infusion' named entity 'embolization' named entity 'healthcare services' named entity 'Aminocaproic acid' named entity 'pain management' named entity 'case reports' named entity 'lidocaine' named entity 'patient-controlled analgesia' named entity 'health care' named entity 'lorazepam' named entity 'irreversibly inhibits' named entity 'tirofiban' named entity 'Sodium bicarbonate' named entity 'stenting' named entity 'analgesics' named entity 'rFVIIa' named entity 'Neurocritical Care Society' named entity 'emergency department' named entity 'morphine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software